Le Lézard
Classified in: Science and technology
Subjects: Conference, Event

Wolters Kluwer to showcase innovative legal solutions at 2024 CLOC Global Institute


Wolters Kluwer will bring a series of dynamic solution lab sessions to the 2024 Corporate Legal Operations Consortium (CLOC) Global Institute. These presentations are designed to support and inspire legal professionals as they leverage innovative solutions, make empowered decisions and drive exceptional results. Attracting a diverse and global audience that comprises multiple sectors of the legal industry, the 2024 CLOC Global Institute will be held from May 6 to 9 at the ARIA Resort & Casino in Las Vegas, NV.

Digitally Transform Your Corporate Legal Department: The Case for Legal Ticketing

Attendees will focus on the streamlined intake and request management process made possible by the new Legal Ticketing feature recently added to Legisway, Wolters Kluwer's all-in-one SaaS legal information and contract management solution for corporate legal departments.

When: May 7, at 11am PT

Where: Pinyon Ballroom

Expert Speakers:

Total Spend Management: Controlling Costs, Increasing Compliance, and Delivering Value

Attendees will discover how solutions like LegalCollaborator, a transformational new legal engagement and competitive bidding tool from ELM Solutions, are helping legal operations professionals create a scalable process for managing the outside counsel experience from start to finish.

When: May 8, at 3pm PT

Where: Pinyon Ballroom 3

Expert Speakers:

Attendees can learn more about how LegalCollaborator is helping legal operations professionals build stronger law firm relationships by visiting Wolters Kluwer in the Exhibit Hall at Booth 101. Solutions experts will also be standing by to help visitors learn more about how they can mitigate bottlenecks using Legisway's key performance indicators for resource management and self-service, or supercharge spend management with ELM Solutions' AI-powered LegalVIEW BillAnalyzer.

For more information about Wolters Kluwer's please visit: www.wolterskluwer.com.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2023 annual revenues of ?5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: